The neuroprotective activity of ferulic acid is well-established and it is currently adopted as a potential pharmacophore in drug discovery processes for Alzheimer’s disease due to its multimodal mechanism of action which combines antioxidant and antiaggregant effects against Aβ oligomers with a Cholinesterase inhibition and a significant anti-inflammatory activity [60]. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.